EUVIMEDEUVIMED entdecken
Crossref

Serotonylation in tumor-associated fibroblasts contributes to the tumor-promoting roles of serotonin in colorectal cancer

Tianlong Ling, Zhanghan Dai, Houming Wang, Tran Trung Kien, Rong Cui, Tachung Yu, Jianjun Chen

Cancer Letters · 2024-09 · 600 · 217150

DOI: 10.1016/j.canlet.2024.217150 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2024-09. Verfasst von Tianlong Ling und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Serotonin, Cancer-Associated Fibroblasts, Cell Proliferation. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Shanghai Minhang Science and Technology Commission, Shanghai Minhang District Health Commission, Science and Technology Commission of Shanghai Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Accumulated studies have highlighted the diverse roles of 5-hydroxytryptamine (5-HT), or serotonin, in cancer biology, particularly in colorectal cancer (CRC). While 5-HT primarily exerts its effects through binding to various 5-HT receptors, receptor-independent mechanisms such as serotonylation remain unclear. This study revealed that depleting 5-HT, either through genetic silencing of Tph1 or using a selective TPH1 inhibitor, effectively reduced the growth of CRC tumors. Interestingly, although intrinsic 5-HT synthesis exists in CRC, it is circulating 5-HT that mediates the cancer-promoting function of 5-HT. Blocking the function of 5-HT receptors showed that the oncogenic roles of 5-HT in CRC operate through a mechanism that is separate from its receptor. Instead, serotonylation of histone H3Q5 (H3Q5ser) was found in CRC cells and cancer-associated fibroblasts (CAFs). H3Q5ser triggers a phenotypic switch of CAFs towards an inflammatory-like CAF (iCAF) subtype, which further enhances CRC cell proliferation, invasive characteristics, and macrophage polarization. Knockdown of the 5-HT transporter SLC22A3 or inhibition of TGM2 reduces H3Q5ser levels and reverses the tumor-promoting phenotypes of CAFs in CRC. Collectively, this study sheds light on the serotonylation-dependent mechanisms of 5-HT in CRC progression, offering insights into potential therapeutic strategies targeting the serotonin pathway for CRC treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsSerotoninCancer-Associated FibroblastsCell ProliferationTryptophan HydroxylaseHumansAnimalsMiceHistonesCell Line, TumorReceptors, SerotoninMale

Stichwörter der Autor:innen

Serotonin transporterSerotonylationTransglutaminasesTumor-associated macrophages

Substanzen

SerotoninTryptophan HydroxylaseHistonesTPH1 protein, humanReceptors, Serotonin

Autor:innen und Institutionen

  • Department of Gastrointestinal Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China.
  • Department of Gastroenterology and Hepatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China.
  • Department of General Surgery, Jiading Hospital of Traditional Chinese Medicine, Jiading District, Shanghai, China.
  • Oncology Department, University Medical Shing Mark Hospital, 1054 Highway 51, Long Binh Tan Ward, Bien Hoa City, Dong Nai, Viet Nam.
  • Department of Gastrointestinal Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China. Electronic address: drcuirong@163.com.
  • Division of Gastroenterology and Hepatology, Shanghai Institute of Digestive Disease, NHC Key Laboratory of Digestive Diseases, State Key Laboratory for Oncogenes and Related Genes, Renji Hospital, School of Medicine, S…

Förderung

  • Shanghai Minhang Science and Technology Commission
  • Shanghai Minhang District Health Commission
  • Science and Technology Commission of Shanghai Municipality

Zitieren

APA

Ling, T., Dai, Z., Wang, H., Kien, T. T., Cui, R., Yu, T., & Chen, J. (2024). Serotonylation in tumor-associated fibroblasts contributes to the tumor-promoting roles of serotonin in colorectal cancer. Cancer Letters, 600, 217150. https://doi.org/10.1016/j.canlet.2024.217150

Vancouver

Ling T, Dai Z, Wang H, Kien TT, Cui R, Yu T, et al. Serotonylation in tumor-associated fibroblasts contributes to the tumor-promoting roles of serotonin in colorectal cancer. Cancer Letters. 2024;600:217150. doi:10.1016/j.canlet.2024.217150

BibTeX
@article{Ling2024,
  author = {Ling, Tianlong and Dai, Zhanghan and Wang, Houming and Kien, Tran Trung and Cui, Rong and Yu, Tachung and Chen, Jianjun},
  title = {Serotonylation in tumor-associated fibroblasts contributes to the tumor-promoting roles of serotonin in colorectal cancer},
  journal = {Cancer Letters},
  year = {2024},
  volume = {600},
  pages = {217150},
  doi = {10.1016/j.canlet.2024.217150}
}
Kostenlos starten →